Back to top
more

Charles River Laboratories International (CRL)

(Real Time Quote from BATS)

$193.51 USD

193.51
208,939

-0.57 (-0.29%)

Updated Oct 2, 2024 12:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 25% (190 out of 252)

Industry: Medical Services

Better trading starts here.

Zacks News

Charles River Laboratories (CRL) Earnings Expected to Grow: Should You Buy?

Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks.com featured highlights include: Design System, The Toro Company, Charles River Laboratories International and ICON

Zacks.com featured highlights include: Design System, The Toro Company, Charles River Laboratories International and ICON

4 GARP Stocks for a Winning Portfolio

Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

Icon PLC (ICLR) Hits Fresh High: Is There Still Room to Run?

Icon PLC (ICLR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?

Charles River (CRL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Charles River (CRL) Soars to 52-Week High, Time to Cash Out?

Charles River (CRL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Charles River Laboratories (CRL) Q3 Earnings Beat Estimates

Charles River (CRL) delivered earnings and revenue surprises of 3.05% and -0.33%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Healthcare Stock Earnings Slated on Nov 6: HUM, ELAN & More

Rise in senior population, shift of care to lower-cost settings and decline in unemployment are likely to have driven healthcare sector earnings.

Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LabCorp (LH) Names Two Leaders for Major Business Wings

Managenment believes that under Schechter's term with Paul and John's crucial support, LabCorp (LH) looks well-positioned to grow and thrive in times ahead.

What Makes Charles River (CRL) a New Buy Stock

Charles River (CRL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Charles River Laboratories (CRL) Q2 Earnings Beat Estimates

Charles River (CRL) delivered earnings and revenue surprises of 5.16% and -0.74%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Healthcare Stock Q2 Earnings Due on Jul 31: HUM, AMED & More

Healthcare stocks like HUM, AMED, CRL, TDOC and PRAH are likely to benefit from higher membership and revenues in the second quarter.

Earnings Preview: Charles River Laboratories (CRL) Q2 Earnings Expected to Decline

Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates

Charles River (CRL) delivered earnings and revenue surprises of 1.45% and 0.70%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Charles River Laboratories (CRL) Q1 Earnings Preview: What's in the Cards?

Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Teladoc's Partnership to Form Pediatric Telehealth Platform

Teladoc (TDOC) teams up with Cincinnati Children's Hospital Medical Center to launch consumer pediatric telehealth platform.

Top Ranked Growth Stocks to Buy for April 12th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, April 12th.

Charles River Laboratories (CRL) Is Up 2.99% in One Week: What You Should Know

Does Charles River Laboratories (CRL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks.com featured highlights include: Cadence Design, LPL, Charles and Automatic Data

Zacks.com featured highlights include: Cadence Design, LPL, Charles and Automatic Data

4 GARP Stocks for a Winning Portfolio

Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

Charles River (CRL) Hits 52-Week High, Can the Run Continue?

Charles River (CRL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Top Ranked Growth Stocks to Buy for April 2nd

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 2nd

Urmimala Biswas headshot

Encouraging Near-Term Outlook for Medical Services Industry

With growing importance of effective healthcare management, the medical service industry is becoming an integral part of the modern healthcare mechanism.

The Zacks Analyst Blog Highlights: General Motors, Charles River, DSW, Shoe Carnival and Boingo

The Zacks Analyst Blog Highlights: General Motors, Charles River, DSW, Shoe Carnival and Boingo